Search is Powered by Google
Follow us on:
Follow our health news on Twitter
Follow Our News on Facebook
Personalization
login | register
Pharma Industry / Biotech Industry News

Are Pharmaceutical Companies Inventing Diseases, New Study Suggests They Are

rate icon Featured Article
Main Category: Pharma Industry / Biotech Industry
Also Included In: Public Health
Article Date: 11 Apr 2006 - 10:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  
Current Article Ratings:

Patient / Public:5 stars

4.91 (11 votes)

Health Professional:5 stars

4.67 (6 votes)

Article Opinions: 0 posts

According to a report in the Public Library of Science and Medicine, pharmaceutical companies are inventing diseases in order to up their sales figures. Scientists at the University of Newcastle, Australia, said such conditions as the menopause are being medicalised by the industry.

Weaved into 'lllnesses' are such reports as 'sexual dysfunction affects 43% of US females', say David Henry and Ray Moynihan, authors of the report. They added that high cholesterol and osteoporosis are being labelled 'diseases' by the industry.

Restless leg syndrome, a relatively rare condition are being blown out of all proportions, they say.

Disease Awareness Campaigns, funded by the industry, are aimed at promoting drug sales rather than informing people about how to take preventive measures.

The researchers accuse the industry of widening the boundaries of illness, which results in more treatments for these 'illnesses', said the researchers.

They added that pharmaceutical industry marketers have the ability to manipulate health professionals and advocacy groups, whose aims are the welfare of patients.

The pharmaceutical industry says it does not invent diseases. It states that it is up to doctors to decide what a disease is.

Disease mongering turns healthy people into patients, wastes precious resources, and causes iatrogenic harm. Like the marketing strategies that drive it, disease mongering poses a global challenge to those interested in public health, demanding in turn a global response. This theme issue of PLoS Medicine is explicitly designed to help provoke and inform that response. See full article.

Ray Moynihan and David Henry are the guest editors of the April 2006 theme issue of PLoS Medicine on disease mongering. Ray Moynihan is a journalist, documentary maker, author, and conjoint lecturer at the University of Newcastle, Newcastle, New South Wales, Australia, and recently co-authored Selling Sickness: How the World's Biggest Pharmaceutical Companies Are Turning Us All into Patients (Nation Books, New York, 2005). David Henry is a professor of clinical pharmacology at the University of Newcastle, Newcastle, New South Wales, Australia, and co-founder of Media Doctor (www.mediadoctor.org.au), a Web site that monitors media coverage of medicine.

Public Library of Science and Medicine

Written by: Christian Nordqvist
Editor: Medical News Today
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today





Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Monthly Feature

Drowning Image
Drowning Doesn't Look Like You May Think It Does...

If you are heading to the water this summer, ask yourself this question - would you be able to spot someone in trouble in the water, in time to save their life? Read our article here...

Forum Icon

Pharma Industry Forum

Discuss issues relating to pharma industry / biotech industry in our new forum.

Visit the pharma industry forum


These are the most read articles from this news category for the last 6 months:
Top Article Star
Lupus Drug Benlysta® (belimumab) Priority Review Granted By FDA
20 Aug 2010
Benlysta® (belimumab), a potential treatment for systemic lupus erythematosus has been granted a priority review designation by the FDA (Food and Drug Administration, USA), which is granted to medications, that if...


Follow Our News On Twitter:
Pharma Industry

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply click the link below and select the 'follow' option.